Skip to content
Synopulse
  • News
  • Editor’s Feature
  • NeuroPulse
  • Industry Trends
    • Market Access
    • Deals
    • Technologies
      • Cell & Gene Tx
      • Antibody
      • AI
      • MedTech
    • Legal, Antitrust & IP
    • Speciality
      • Neurology
      • Orthopaedics
      • Oncology
      • Cardiometabolic
      • Pediatrics
  • Regulatory
    • FDA Updates
    • EMA Updates
    • Global Compliance
    • About US

Market Pulse

CMS Unveils 2027 Negotiated Prices, Delivering Major Savings Across 15 Drugs

November 27, 2025 by Shajini
CMS Unveils 2027 Negotiated Prices, Delivering Major Savings Across 15 Drugs

CMS has issued the CY 2026 ESRD PPS final rule, introducing a higher base rate, new geographic adjustments, revised outlier policies, and changes to the ESRD Quality Incentive Program.

Categories Cardiometabolic, Market Pulse, Neurology, News, Oncology Tags Centers for Medicare & Medicaid Services, CMS
Synopulse Weekly Pulse: Access Decisions, Regulatory Events & Market Dynamics, Week of Nov 24 2025

Synopulse Weekly Pulse – November 24, 2025

Read Now
  • AI
  • Antibody
  • Cardiometabolic
  • Cell & Gene Tx
  • Deals
  • Dealstreet
  • Device Approvals
  • Editor’s Feature
  • EMA Updates
  • FDA Updates
  • Global Compliance
  • HTA
  • Industry Trends
  • Legal, Antitrust & IP
  • Litigation, Law & Policy
  • Market Access
  • Market Pulse
  • MedTech
  • Monthly Insight's
  • Neurology
  • NeuroPulse
  • News
  • Oncology
  • Orthopaedics
  • Pediatrics
  • Pricing and Reimbursement
  • Regulatory
  • Weekly Pulse
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • June 2025
  • February 2025
  • January 2025
  • October 2024
  • September 2024
Synopulse
Contact Us

Explore Synopulse

  • NeuroPulse
  • Deals
  • Market Access
  • Industry Trends
  • Regulatory

About

  • About Synopulse
  • Contact Us
  • Announcements
© 2026 Synopulse • Built with GeneratePress